Citations

Clear

108 citation(s) found for "Spaulding, Aaron".

Barriers to accepting mental health care in cancer patients with depression
Niazi, Shehzad K. , Vargas, Emily , Spaulding, Aaron , Gustetic, Elaine, Ford, Nancy, Paly, David, Tatum, Kelsey, Clark, Matthew M. , Rummans, Teresa A. , Brennan, Emily , Niazi, Shehzad, Rummans, Teresa, Spaulding, Aaron , Ford, Nancy

Mayo Clinic

Social Work in Health Care | June 15, 2020 | Volume: 59 | Issue: 6 | Pages: 351-364

10.1080/00981389.2020.1769248 | PMID 32536332 Get It

Disparities in Access to Autologous Breast Reconstruction
Restrepo, David J. , Huayllani, María T. , Nguyen, Minh-Doan T., Cochuyt, Jordan J., Spaulding, Aaron , Rinker, Brian, Forte, Antonio J. , Boczar, Daniel , Spaulding, Aaron , Forte, Antonio Jorge , Sisti, Andrea , Nguyen, Minh-Doan T. , Perdikis, Galen

Mayo Clinic

Medicina | June 9, 2020 | Volume: 56 | Issue: 6 | Pages: 281

10.3390/medicina56060281 | PMID 32521732 Get It

Background and objectives: This study aimed to determine if age, race, region, insurance, and comorbidities affect the type of breast reconstruction that patients receive. Materials and methods: This analysis used the Florida Inpatient Discharge Dataset from 1 January 2013 to 30 September 2017, which contains deidentified patient-level administrative data from all acute care hospitals in the state of Florida. We included female patients, diagnosed with breast cancer, who underwent mastectomy and a subsequent breast reconstruction. We performed an χ2 test and logistic regression in this analysis. Results: On the multivariable analysis, we found that age, race, patient region, insurance payer, and Elixhauser score were all variables that significantly affected the type of reconstruction that patients received. Our results show that African American (odds ratio (OR): 0.68, 95%CI: 0.58–0.78, p < 0.001) and Hispanic or Latino (OR: 0.82, 95%CI: 0.72–0.93, p = 0.003) patients have significantly lower odds of receiving implant reconstruction when compared to white patients. Patients with Medicare (OR: 1.57, 95%CI: 1.33–1.86, p < 0.001) had significantly higher odds and patients with Medicaid (OR: 0.61, 95%CI: 0.51–0.74, p < 0.001) had significantly lower odds of getting autologous reconstruction when compared to patients with commercial insurance. Conclusions: Our study demonstrated that, in the state of Florida over the past years, variables, such as race, region, insurance, and comorbidities, play an important role in choosing the reconstruction modality. More efforts are needed to eradicate disparities and give all patients, despite their race, insurance payer, or region, equal access to health care.
Abstract QS19: National Analysis Of Patients Diagnosed With Melanoma At Autopsy Alone
Huayllani, María T. , Cinotto, Gabriela, Rinker, Brian, Manrique, Oscar J. , Forte, Antonio J. , Forte, Antonio Jorge , Boczar, Daniel , Spaulding, Aaron , Bagaria, Sanjay P.

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | May 12, 2020 | Volume: 8 | Issue: 4S | Pages: 149-149

10.1097/01.gox.0000667932.35742.45 Get It

Abstract 86: Investigating Treatment Contraindication Based On Comorbidity Status In Patients Diagnosed With Melanoma In The United States
Huayllani, María T. , Cinotto, Gabriela, Rinker, Brian, Manrique, Oscar J. , Forte, Antonio J. , Forte, Antonio Jorge , Boczar, Daniel , Spaulding, Aaron , Bagaria, Sanjay P.

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | May 12, 2020 | Volume: 8 | Issue: 4S | Pages: 56-56

10.1097/01.gox.0000667404.48973.00 Get It

Abstract 15: Factors That Influence Survival Of Chondrosarcoma Of The Upper Extremities
Cinotto, Gabriela, Huayllani, María T. , Bczar, Daniel, Spaulding, Aaron , Wilker, Benjamin, Forte, Antonio J. , Forte, Antonio Jorge , Spaulding, Aaron , Bagaria, Sanjay P.

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | May 12, 2020 | Volume: 8 | Issue: 4S | Pages: 10-11

10.1097/01.gox.0000667124.40689.e7 Get It

Paget disease of the breast: A national retrospective analysis of the US population
Huayllani, María T. , Restrepo, David J. , Advani, Pooja , Lu, Xiaona , Spaulding, Aaron , Ball, Colleen T. , McLaughlin, Sarah A. , Forte, Antonio J. , Boczar, Daniel , Spaulding, Aaron C. , Forte, Antonio Jorge , Spaulding, Aaron , Sisti, Andrea

Mayo Clinic

Breast Disease | May 8, 2020 | Volume: 39 | Issue: 3-4 | Pages: 119-126

10.3233/bd-200439 | PMID 32390594 Get It

BACKGROUND: Paget’s disease of the breast is rare. The National Cancer Database (NCDB) is one of the largest tumor databases in the United States. METHODS: We queried the NCDB to identify male and female patients with Paget’s disease of the breast who were treated from January 1, 2004, through December 31, 2015. No age limitations were applied. Descriptive statistical analysis and survival analysis were performed. RESULTS: We analyzed the demographic, disease, and treatment characteristics of 7,191 patients with Paget’s disease of the breast. The median (range) age was 64 (20–90) years. Only 2.1% of patients were men, and 85.4% were white. The most common treatment was complete mastectomy (65.3%), followed by partial mastectomy (30.3%). Tumor destruction was performed in 0.1% of patients, and 4.3% of patients did not undergo any surgery. We examined survival in the subset of 6,864 patients who were treated surgically with complete mastectomy or partial mastectomy. The 5-year survival rate after surgery was 82.5% (95% CI, 81.1%–83.9%). Factors associated with shorter survival were older age, black race/ethnicity, higher tumor grade, regional lymph node metastasis, higher cancer stage, metastatic cancer, and larger tumor size. CONCLUSIONS: Paget’s disease of the breast usually affects patients older than 60 years, and the most common treatment is complete mastectomy. The 5-year overall survival rate of patients with Paget’s disease of the breast is greater than 80% but is lower among older and black people.
Patient-Reported Use of Medical Cannabis for Management of Chronic Pelvic Pain [12H]
Carrubba, Aakriti R. , Ebbert, Jon O. , DeStephano, Christopher C. , Spaulding, Aaron

Mayo Clinic

Obstetrics & Gynecology | April 25, 2020 | Volume: 135 | Issue: 1 | Pages: 84S-84S

10.1097/01.aog.0000665024.52449.e7 Get It

INTRODUCTION: Chronic pelvic pain (CPP) affects up to 15% of women in the United States. The endocannabinoid system can be a pharmacological target for endometriosis-related pelvic pain, as cannabis receptors are highly expressed in the uterus and other non-reproductive tissues. We hypothesize that many patients with CPP use cannabis and report improvement in symptoms. METHODS: An anonymous, confidential, electronic survey was performed from March through August 2019. Patients aged 18 through 89 were included if they had a diagnosis of pelvic/perineal pain, dyspareunia, or endometriosis. Subjects were approached during outpatient appointments. Study approval was obtained from the Institutional Review Board. RESULTS: A total of 122 of 240 (50.8%) patients responded. Of these, 113 self-reported a diagnosis of CPP (92.6%). Twenty-six patients reported cannabis use (23%). Six (24%) used Cannabidiol (CBD), 3 (12%) used tetrahydrocannabinol (THC), and 15 (60%) used a combination of CBD and THC. Frequency of use varied, with the majority using at least once per week (n=18, 69.2%). Only 5 (19.2%) utilized a State Medical Cannabis Program to obtain a certification. Of users, 24 (92.3%) reported improvement in symptoms, including pain, cramping, muscle spasms, anxiety, depression, sleep disturbances, libido, and irritability. However, 21 (80.7%) reported side effects; the most common were dry mouth, sleepiness, and feeling “high.” CONCLUSION: Up to 23% of patients with CPP report use of cannabis as an adjunct to their prescribed therapy, and they use a variety of formulations and doses. Most report daily or weekly use. Although side effects are common, most users report improvement in symptoms.
Hospital-Acquired Conditions Reduction Program, Patient Safety, and Magnet Designation in the United States
Hamadi, Hanadi, Borkar, Shalmali R., Moody, LaRee, Tafili, Aurora, Wilkes, J. Scott, Franco, Pablo Moreno, McCaughey, Deirdre, Spaulding, Aaron, Spaulding, Aaron , Tafili, Aurora , Moreno Franco, Pablo, Spaulding, Aaron , Hamadi, Hanadi, Borkar, Shalmali R., Moody, LaRee, Wilkes, J. Scott, Franco, Pablo Moreno, McCaughey, Deirdre

Mayo Clinic

Journal of Patient Safety | March 26, 2020 | Volume: 17 | Issue: 8 | Pages: e1814-e1820

10.1097/pts.0000000000000628 | PMID 32217925 Get It

Objective The aim of the study was to investigate the association between hospitals’ nursing excellence accreditation and patient safety performance—measured by the Hospital-Acquired Conditions Reduction Program (HACRP). Methods We linked data from the American Nursing Credentialing Center Magnet Recognition Program, Centers for Medicare and Medicaid Services HACRP, and the American Hospital Association annual survey from 2014 to 2016. We constrained the analysis to hospitals participating in Centers for Medicare and Medicaid Services’ HACRP and deployed propensity score matching models to calculate the coefficients for our HACRP patient safety measures. These measures consisted of (a) patient safety indicator 90, (b) hospital-associated infection measures, and (c) total HAC scores. In addition, we used propensity score matching to assess HACRP scores between hospitals achieving Magnet recognition in the past 2 versus longer and within the past 5 years versus longer. Results Our primary findings indicate that Magnet hospitals have an increased likelihood of experiencing lower patient safety indicator 90 scores, higher catheter-associated urinary tract infection and surgical site infection scores, and no different total HAC scores. Finally, when examining the impact of Magnet tenure, our analysis revealed that there were no differences in Magnet tenure. Conclusions Results indicate that the processes, procedures, and educational aspects associated with Magnet recognition seem to provide important improvements associated with care that is controlled by nursing practice. However, because these improvements do not differ when comparing total HAC scores nor Magnet hospitals with different tenure, there are likely opportunities for Magnet hospitals to continue process improvements focused on HACRP scores.
Acute Mesenteric Ischemia Remains a Highly Morbid Diagnosis after Initial Hospitalization Survival
Spaulding, Aaron , Oderich, Gustavo S. , Rocha-Franco, Joao A. Da, Farres, Houssam , Cochuyt, Jordan J., Sorrells, William S., Oldenburg, A, Frey, G. , Toskich, Beau B. , Becher, Robert D. , Hakaim, Albert G., Spaulding, Aaron , Erben, Young , Oderich, Gustavo S. , Oldenburg, A. W.

Mayo Clinic

International Journal of Angiology | March 5, 2020 | Volume: 29 | Issue: 03 | Pages: 189-195

10.1055/s-0039-1700984 | PMID 33100803 Get It

AbstractAcute mesenteric ischemia (AMI) remains a vascular emergency. Our aim was to explore readmission for AMI. We identified all patients admitted for AMI from the state of California through the Healthcare and Utilization Project from 2005 to 2011. Our primary end point was the rate and etiology for readmission. Our secondary end points were the length of hospitalization and in-hospital mortality. Cox proportional hazard regression was utilized to assess risk of 30-day readmission. There were 534 (9.9%) readmissions at 30 days. The mean age was 67 ± 17 years and 209 (39.1%) were male. The five most common etiologies for readmission were AMI (7.6%), cardiac events (5.3%), severe sepsis (1.2%), dehydration (1.1%), and acute kidney failure (1.1%). Once readmitted, these patients were most likely to experience cardiac catheterizations (25.4%), red blood cell transfusions (23.6%), intubation and mechanical ventilation (17.6%), biopsy of the large intestine (13.9%), reoperation for small bowel resection (10.9%), administration of total parenteral nutrition (10.5%), and transfusion of other blood products (6.9%). This hospitalization was 8.8 ± 12.7 days long. In-hospital mortality was 36 patients (6.7%). On multivariable Cox-regression analysis, severe (hazard ratio [HR]: 2.1 [1.4–3.2], p = 0.0005) and moderate (HR: 1.5 [1.03–2.13], p = 0.04) Elixhauser Comorbidity Group, complications (HR: 1.5 [1.2–1.9], p = 0.0007), and longer index hospitalization (HR: 1.02 [1.01–1.02], p < 0.0001) were predictors of readmission. Conclusion AMI remains a vascular emergency. Readmissions have a significant rate of morbid invasive procedures and can lead to an in-hospital mortality of 6.7%. The adoption of guidelines similar to the European Society for Trauma and Emergency Surgery should be considered.
Artificial Intelligent Virtual Assistant for Plastic Surgery Patient's Frequently Asked Questions
Oliver, Jeremie D. , Helmi, Haytham , Restrepo, David J. , Huayllani, María T. , Spaulding, Aaron , Carter, Rickey E. , Rinker, Brian, Forte, Antonio J. , Spaulding, Aaron C. , Carter, Rickey, Forte, Antonio Jorge , Spaulding, Aaron , Oliver, Jeremie D , Carter, Rickey E , Boczar, Daniel , Sisti, Andrea

Mayo Clinic

Annals of Plastic Surgery | February 6, 2020 | Volume: 84 | Issue: 4 | Pages: e16-e21

10.1097/sap.0000000000002252 | PMID 32032120 Get It

Background Artificial Intelligent Virtual Assistants (AIVA) is a segment of artificial intelligence that is rapidly developing. However, its utilization to address patients' frequently asked questions remains unexplored. Methods We developed an AIVA to answer questions related to 10 frequent topics asked by plastic surgery patients in our institution. Between July 27, 2018, and August 10 of 2018, we recruited subjects with administrative positions at our health care institution to chat with the virtual assistant. They asked, with their own words, 1 question for each topic and filled out a satisfaction questionnaire. Postsurvey analysis of questions and answers allowed assessment of the virtual assistant's accuracy. Results Thirty participants completed the survey. The majority was female (70%), and the mean age was 27.76 years (SD, 8.68 [19–51] years). The overall accuracy of the plastic surgery AIVA was 92.3% (277/294 questions), and participants considered the answer correct in 83.3% of the time (250/294 answers). Most of the participants considered the AIVA easy to use, answered adequately, and could be helpful for patients. However, when asked if this technology could replace a human assistant, they stayed neutral.